全球神经復健设备市场规模、份额、成长分析、按产品、按治疗领域 - 产业预测 2023-2030

2022年全球神经復健设备市场规模为24.9亿美元，从2023年的28.9亿美元成长到2031年，预测期间（2024-2031年）复合年增长率为15.9%，预计将成长至94亿美元2019年。

该市场旨在满足中风、多发性硬化症、帕金森氏症和脑性麻痹等多种神经系统疾病对有效復健干预措施日益增长的需求。推动该市场成长的主要因素是由于人口老化和生活方式改变等因素导致全球神经系统疾病盛行率上升。因此，越来越需要创新的解决方案来帮助恢復和管理这些状况。神经復健设备提供个人化治疗，旨在帮助患者恢復独立性并提高功能能力。儘管人工智慧、虚拟实境和机器人等技术进步带来了机会，但神经復健设备市场也遇到了挑战。这包括需要持续研究和开发以提高设备的有效性和易用性。在将此类技术引入临床之前，需要进行广泛的研究、临床试验和监管部门的核准。然而，全球神经復健设备市场在满足神经系统疾病患者的復健需求方面发挥着重要作用。虽然流行率上升等因素正在推动市场成长，但也存在高成本和限制性报销政策等挑战。然而，持续的研究和发展提供了整合新技术和扩大神经復健服务机会的机会。总而言之，神经復健设备市场在改善患者生活和推动神经復健治疗方面具有巨大潜力。

目录

执行摘要

• 市场概况
• 命运之轮

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管形势
• 波特的分析
• 对未来中断的特殊考虑

全球神经復健设备市场：副产品

• 市场概况
• 神经机器人学
• 脑机介面
• 穿戴式装置
• 非侵入性刺激器

全球神经復健设备市场：按治疗领域

• 市场概况
• 中风
• 多发性硬化症
• 帕金森氏症
• 脑性麻痹
• 其他的

全球神经復健设备市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争形势

• 5大公司比较
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• Medtronic（US）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• Stryker Corporation（US）
• Smith & Nephew plc（UK）
• Bioness Inc.（US）
• Hocoma AG（Switzerland）
• St. Jude Medical（US）
• Ekso Bionics Holdings, Inc.（US）
• Bioxtreme Robotics Rehabilitation（Italy）
• ReWalk Robotics Ltd.（Israel）
• Neurostyle Pte. Ltd.（Singapore）
• Kinova Robotics（Canada）
• Neuro Rehab VR（US）
• Tyromotion GmbH（Austria）
• Neofect（South Korea）
• Enraf-Nonius（Netherlands）
• Hobbs Rehabilitation（UK）
• Motek Medical BV（Netherlands）
• Biodex Medical Systems, Inc.（US）

Global Neurorehabilitation Devices Market size was valued at USD 2.49 Billion in 2022 and is poised to grow from USD 2.89 Billion in 2023 to USD 9.40 Billion by 2031, at a CAGR of 15.9% during the forecast period (2024-2031).

The market aims to meet the rising demand for effective rehabilitation interventions for diverse neurological conditions including stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy, among others. A key factor driving the growth of this market is the escalating prevalence of neurological disorders worldwide, attributed to factors like aging populations and lifestyle changes. Consequently, there is a significant need for innovative solutions aiding in the recovery and management of these conditions. Neurorehabilitation devices provide personalized therapies targeted at helping patients regain independence and enhance functional abilities. Despite opportunities presented by technological advancements like artificial intelligence, virtual reality, and robotics, the neurorehabilitation devices market encounters challenges. These include the necessity for continuous research and development to enhance device effectiveness and usability. Integrating such technologies into clinical practice requires extensive research, clinical trials, and regulatory approvals. Nevertheless, the global neurorehabilitation devices market plays a vital role in meeting the rehabilitation needs of individuals with neurological conditions. While factors such as increasing prevalence drive market growth, challenges such as high costs and limited reimbursement policies exist. Yet, ongoing research and development efforts present opportunities to integrate emerging technologies and broaden access to neurorehabilitation services. Ultimately, the neurorehabilitation devices market holds significant promise in improving patient lives and advancing neurorehabilitation therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurorehabilitation Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Neurorehabilitation Devices Market Segmental Analysis

The global neurorehabilitation devices market is segmented on the basis of product, therapy area, and region. In terms of product, the market is segmented into Neurorobotics, Brain-computer interface, Wearable devices, and Non-invasive Stimulators. By Therapy Area, the market is segmented into Refrigerant, Industrial Solvent, Silicone Polymers, Laboratory Chemicals, Chemical Intermediates, Methylating & Chlorinating Agent, Propellant & Blowing Agent, Catalyst Carrier, Herbicide, Local Anesthetic, Adhesives and Sealants, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurorehabilitation Devices Market

A key factor propelling the neurorehabilitation devices market is the ongoing progress in technology. Recent years have witnessed notable advancements in fields like robotics, virtual reality, wearable sensors, and brain-computer interfaces. These advancements have facilitated the creation of more refined and efficient neurorehabilitation devices, offering tailored therapies and individualized rehabilitation solutions for patients. For instance, robotic exoskeletons such as Ekso Bionics' EksoGT and ReWalk Robotics' ReWalk system are developed to aid individuals with mobility limitations in walking and enhancing their motor abilities.

The increasing occurrence of neurological conditions like stroke, multiple sclerosis, and Parkinson's disease is fuelling the need for neurorehabilitation devices. As per the World Health Organization, the global impact of neurological disorders is on the rise, primarily influenced by factors such as aging demographics and shifts in lifestyle patterns. Consequently, there's an escalating demand for efficient rehabilitation strategies aimed at assisting individuals in restoring functionality and enhancing their overall well-being.

Restraints in the Global Neurorehabilitation Devices Market

One of the main restraints in the neurorehabilitation devices market is the high cost associated with these devices. Advanced technologies, such as robotics and brain-computer interfaces, can make the devices expensive. Additionally, the specialized expertise required for their effective utilization can increase the overall cost of treatment. This cost factor can limit the accessibility of neurorehabilitation devices, particularly in regions with limited healthcare resources or inadequate insurance coverage.

Another challenge involves the restricted reimbursement policies concerning neurorehabilitation devices and therapies within certain healthcare systems. Reimbursement policies differ among countries, and in certain instances, the coverage for neurorehabilitation devices might be insufficient. This limited reimbursement scenario can present obstacles for both patients and healthcare providers, impeding the broad adoption of these devices and potentially restricting access to innovative neurorehabilitation treatments.

Market Trends of the Global Neurorehabilitation Devices Market

Tele-rehabilitation emerges as a prominent trend in the neurorehabilitation devices market, characterized by the uptake of remote rehabilitation solutions. Through tele-rehabilitation, patients can remotely access rehabilitation services via technology, connecting with healthcare professionals and participating in therapy sessions from the comfort of their homes. This trend has surged notably amid the COVID-19 pandemic, addressing constraints faced by in-person rehabilitation services. Tele-rehabilitation presents benefits such as convenience, enhanced accessibility, and opportunities for ongoing monitoring and personalized care

Customized and Dynamic Innovations: The neurorehabilitation market is experiencing a shift towards the creation of customized and adaptable technologies. These innovations strive to customize rehabilitation approaches based on the unique requirements, abilities, and progress of individual patients. Progress in sensor technology, artificial intelligence, and data analysis facilitates the gathering and assessment of patient-specific data, enabling the implementation of more precise and efficient rehabilitation regimens. Customized and adaptable technologies present the opportunity for improved results and increased patient involvement.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Neurorehabilitation Devices Market by Product

• Market Overview
• Neurorobotics
• Brain-computer interface
• Wearable devices
• and Non-invasive Stimulators

Global Neurorehabilitation Devices Market by Therapy Area

• Market Overview
• Stroke
• Multiple Sclerosis
• Parkinson's Disease
• Cerebral Palsy
• and Others

Global Neurorehabilitation Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioness Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hocoma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ekso Bionics Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioxtreme Robotics Rehabilitation (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReWalk Robotics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurostyle Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kinova Robotics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuro Rehab VR (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tyromotion GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neofect (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enraf-Nonius (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Rehabilitation (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Motek Medical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biodex Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments